Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma.

scientific article published on April 2010

Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1346-8138.2010.00826.X
P698PubMed publication ID20507401

P50authorMiguel HuertaQ57339571
P2093author name stringDelgado-Enciso Iván
Enríquez-Casillas Rubén
Fraga-Mouret Antonio
Ochoa-Ramírez Agustín
Vázquez-Rodríguez Manuel
P433issue4
P304page(s)323-329
P577publication date2010-04-01
P1433published inThe Journal of DermatologyQ18225322
P1476titleCiprofloxacin utility as antifibrotic in the skin of patients with scleroderma
P478volume37

Reverse relations

cites work (P2860)
Q47835767Assessment of skin involvement in systemic sclerosis
Q39987550Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
Q26799573Management of Systemic-Sclerosis-Associated Interstitial Lung Disease
Q37381549Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives
Q27016132Update on scleroderma-associated interstitial lung disease

Search more.